Development of Novel Microemulsion-Based Topical Formulations of Acyclovir for the Treatment of Cutaneous Herpetic Infections
- 442 Downloads
The present investigation aims at developing microemulsion-based formulations for topical delivery of acyclovir. Various microemulsions were developed using isopropyl myristate/Captex 355/Labrafac as an oil phase, Tween 20 as surfactant, Span 20 as cosurfactant, and water/dimethylsulfoxide (1:3) as an aqueous phase. Transcutol, eucalyptus oil, and peppermint oil were used as permeation enhancers. In vitro permeation studies through laca mice skin were performed using Franz diffusion cells. The optimum formulation containing 2.5% Transcutol as the penetration enhancer showed 1.7-fold enhancement in flux and permeation coefficient as compared to marketed cream and ointment formulation. In vivo antiviral studies were performed in female Balb/c mice against induced herpes simplex virus I infection. A single application of microemulsion formulation containing 2.5% Transcutol given 24 h post-injection resulted in complete suppression of development of herpetic skin lesions.
KEY WORDSacyclovir antiviral herpes simplex virus microemulsion topical
The authors gratefully acknowledge the gift sample of ACV supplied by Arochem Industries (Mumbai, India), Captex 355 EP/NF (Abitec Corporation, UK), and Labrafac CC and Transcutol (Colorcon Asia Pvt. Ltd., India). Authors also thank Prof. Radha Kanta Ratho (Head) and Assistant Prof. Mini P. Singh, Department of Virology, Postgraduate Institute of Medical Education and Research, Chandigarh, India for their help and guidance and for providing laboratory facilities for antiviral studies.
- 7.Aulton ME. Dissolution and solubility. In: Aulton ME, editor. Pharmaceutics. Edinburgh, UK: Churchill Livingstone; 2002. p. 15–32.Google Scholar
- 8.British Pharmacopoeia, Vol. II. The stationary Office, London; 1999, p. A-87.Google Scholar
- 10.Piret J, Desormeaux A, Gourde AP, Juhasz J, Bergeron MG. Efficacies of topical formulations of foscarnet and acyclovir and of 5-percent acyclovir ointment (Zovirax) in a murine model of cutaneous herpes simplex virus type 1 infection. Antimicrob Agents Chemother. 2000;44:30–8.PubMedCrossRefGoogle Scholar
- 11.Schimdt NJ. Cell culture techniques for diagnostics virology. In: Lennette EH, Schimdt NJ, editors. Diagnostic procedure for viral, rickettisial and chlamydial infections. Washington: American Public Health Association; 1979. p. 100–4.Google Scholar
- 13.Davis SS, Hadgraft J, Al-Khamis K. Percutaneous absorption of methyl salicylate from polyethylene glycol vehicles. J Pharm Pharmacol. 1981;33:97P.Google Scholar
- 15.Barret W, Hadgraft JW, Sarnaky I. The influence of vehicles on skin penetration. J Pharm Pharmacol. 1964;16:104T–107T.Google Scholar
- 20.Wang F, Kief E. Viral diseases. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, editors. Harrison’s principles of internal medicine. Singapore: McGraw-Hill; 1998. p. 1076–85.Google Scholar